Pharmaron
pharmaron.com
As featured in
Claim pageClaim
Follow
Overview
Connections
News
Salaries
Products
People
Growth
Offices
Financials
Connections
List
Graph
Found in company registers, site code, DNS and hiring. Each connection shows how sure we are and the evidence, with its source and date.
Shared investors
Aisling CapitalVia a fund
Click a company to open it. Dashed lines are likely connections. The second step of the network is part of the Pro plan.
Owner
Same company
Same group
Likely
News
Pharmaron Acquires Biortus in China
BEIJING, October 28, 2025--Pharmaron entered a Share Purchase Agreement to acquire 82.54% equity interest of Biortus to enhance structure-based drug discovery & protein science.
Read more
Report
CN Bio and Pharmaron Establish Long-Term Strategic Partnership To Develop OOC Technologies on a Global R&D Platform
Read more
Report
CMS(00867) Joins Hands with Pharmaron to Promote the Singapore Manufacturing Plant Acquisition and CDMO Business in SEA
SHENZHEN, CHINA, Jan. 02, 2024 (GLOBE NEWSWIRE) -- On 29 December, 2023, PharmaGend Global Medical Services Pte. Ltd. (
Read more
Report
Pharmaron's Liverpool UK Gene Therapy CDMO Commences Major Site Expansion Following UK Government Grant to Support £151m Investment
Read more
Report
Pharmaron Acquires Commercial API Manufacturing Facility in the United Kingdom from Recipharm
Read more
Report
AbbVie sells biologics plant to Pharmaron, fueling the China company's cell and gene therapy ambitions
Read more
Report
Pharmaron Joins the National Cancer Institute's Chemical Biology Consortium to Fight against Cancer
Read more
Report
Pharmaron Chooses Reaxys To Enhance Productivity and Competitiveness
/PRNewswire/ -- - Reaxys is an Online Workflow Solution Used by Research Chemists to Fuel Their Drug Discovery Processes Elsevier, a world-leading provider of...
Read more
Report